MyBody-X angle on Menopause Genetik

MyBody-X offers DNA tests that analyze certain SNPs (e.g., VDR, MTHFR, FADS1) which may be loosely linked to hormone metabolism or inflammation, but there is no dedicated 'menopause genetics' panel. Menopause is a complex multifactorial process; genetic variants have small effect sizes and are not clinically predictive on their own. The company markets these tests as lifestyle insights, not medical diagnostics. Evidence for actionable menopause-related guidance from such SNPs is weak (mechanistic/GWAS, not human interventional). A blood test for hormone levels (e.g., FSH, estradiol) is far more relevant. Consumers should be cautious: no home DNA test can diagnose or predict menopause timing or severity with clinical accuracy.